ClinicalTrials.Veeva

Menu

Trial to Test if Antibiotic Ointments & Cream Will Sting After Application on a Minor Wound After Tape Stripping Injury

Johnson & Johnson (J&J) logo

Johnson & Johnson (J&J)

Status

Completed

Conditions

Sting

Treatments

Drug: Isopropyl Alcohol
Drug: Pain Relieving Cream
Drug: Saline
Drug: Antibiotic/Pain Relieving Ointment
Drug: Original Ointment
Drug: Pain Relief Ointment

Study type

Interventional

Funder types

Industry

Identifiers

NCT02320695
CO-140617115421-THCT

Details and patient eligibility

About

The purpose of this study is to have subjects report whether or not several antibiotic products sting when they are applied to minor wounds created on the inner arms.

Full description

The primary objective of this study is to assess the sting potential of single applications of over-the-counter (OTC) topical antibiotic ointments and cream compared to saline (negative control) and isopropyl alcohol (positive control) when applied to a tape-stripped wound site.

Enrollment

60 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Males and females, 18-75 years of age, of any race or ethnicity, in generally good health as determined by a medically-qualified individual
  2. Provide a signed and dated informed consent form prior to start of any study-related procedures
  3. Able to comprehend and follow the requirements of the study;
  4. Females of childbearing potential must have a negative urine pregnancy test at the Screening/Baseline visit;
  5. Male or non-pregnant, non-lactating females agree to the contraceptive requirements (including female partner's use of a highly effective form of birth control. Females must have used the same birth control for 1 month before Screening and continue to use it through 1 month after administration of study drug)
  6. Willing and able to comply with the tape stripping and all study procedures and attend the scheduled visits for the duration of the study

Exclusion criteria

  1. Suspected alcohol or substance abuse (e.g., amphetamines, benzodiazepines, cocaine, marijuana, opiates)
  2. Females who are pregnant (positive urine pregnancy test at screening/baseline) or breastfeeding
  3. Males with a pregnant partner or a partner who is currently trying to become pregnant
  4. Using steroidal medication (topical or systemic) currently and within 30 days before Visit 1
  5. Ingestion of systemic anti-histamines or analgesics within the 3 days before Visit 1
  6. Known sensitivity or allergies to the investigational products, to first aid preparations or local anesthetics (e.g. gauze products, pramoxine), or to adhesive bandages
  7. Known allergies to unscented soap
  8. Tendency of forming keloids after wounding
  9. Tattoos located on the surface of one or both inner (volar) region of forearms
  10. Heavily pigmented subjects who could heal with abnormal darkening at the test sites on the inner forearms
  11. Presence of excessive hair on the inner forearms which could interfere with the test procedures
  12. Presents with skin disorders on the inner arms (cuts, scratches, scars, etc), which in the opinion of the Investigator or qualified designee, will interfere with the study assessment or will create undue risk for the subject
  13. Pre-existing or dormant dermatologic skin conditions (e.g., eczema, seborrheic dermatitis, atopic dermatitis, psoriasis, vitiligo, etc.) that could interfere with the outcome of the study as determined by the Investigator or qualified designee
  14. Other medical condition that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the subject inappropriate for entry into this study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

60 participants in 6 patient groups, including a placebo group

Saline
Placebo Comparator group
Description:
0.9% Sodium Chloride Saline Solution (0.3 cc)
Treatment:
Drug: Saline
Isopropyl Alcohol
Placebo Comparator group
Description:
70% Isopropyl Alcohol (0.3 cc)
Treatment:
Drug: Isopropyl Alcohol
Pain Relieving Cream
Experimental group
Description:
Neosporin® Plus Pain Relieving Cream formula with pH balance technology (0.3 cc)
Treatment:
Drug: Pain Relieving Cream
Antibiotic/Pain Relieving Ointment
Experimental group
Description:
Neosporin® Complete First Aid Antibiotic/Pain Relieving Ointment (0.3 cc)
Treatment:
Drug: Antibiotic/Pain Relieving Ointment
Original Ointment
Experimental group
Description:
Neosporin® Original Ointment (0.3 cc)
Treatment:
Drug: Original Ointment
Pain Relief Ointment
Experimental group
Description:
Neosporin® Plus Pain relief Ointment (0.3 cc)
Treatment:
Drug: Pain Relief Ointment

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems